Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endometrial Response Following Use of the Stem Cell Mobilizing Agent AMD3100 in a Population of Infertile Women With a Thin Endometrial Lining

NCT04045821 is registered in ClinicalTrials.gov with Reproductive Medicine Associates of New Jersey as lead sponsor.

NCT NCT04045821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04045821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endometrial Response Following Use of the Stem Cell Mobilizing Agent AMD3100 in a Population of Infertile Women With a Thin Endometrial Lining
Lead sponsor
Reproductive Medicine Associates of New Jersey
Phase
Not applicable
Overall status
Terminated
Start date
January 17, 2020
Completion date
May 4, 2021
Enrollment
3 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

infertility of uterine origin